Ellen Beausang

Director at Aspira Women's Health

Capital raised by Aspira Women's Health

$5.8M+$1.5M latest round

3 Form D filings · first filed Mar 2025 · Austin, TX

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 3
TEAM ON FILE: 4
FOUNDED: —
30D INTEREST: 3 ↗

Career

1 company on file

Aspira Women's HealthBiotech · Austin, TXsince Mar 2025

Director

Listed on Aspira Women's Health's Form D filings

Company filings

via EDGAR · Form D for Aspira Women's Health3

DateCompanyFormAmountRole on filing

Jun 5, 2026Aspira Women's HealthForm D+$1.5M—

Form DJun 5, 2026 · Aspira Women's Health+$1.5Mnot a signer

Sep 16, 2025Aspira Women's HealthForm D+$3.0M—

Form DSep 16, 2025 · Aspira Women's Health+$3.0Mnot a signer

Mar 5, 2025Aspira Women's HealthForm D+$1.4M—

Form DMar 5, 2025 · Aspira Women's Health+$1.4Mnot a signer

Overview

Last filing Jun 5, 2026

Ellen Beausang is on file as Director at Aspira Women's Health in Austin, TX. Aspira Women's Health has 3 Form D filings on record, $5.8M raised in total.

Teammates

Aspira Women's Health · 3

John StrahleyChief Financial OfficerSigner Michael BuhleChief Executive OfficerSigner Winfred ParnellDirector

Products

Aspira Women's Health · 1

OvaSuiteDiagnostic Blood Tests

OvaSuite is a comprehensive suite of blood tests designed to aid in the assessment of ovarian cancer risk. It includes specific tests tailored to monitor and evaluate the presence of malignancy in adnexal masses.